vs
Side-by-side financial comparison of Great Lakes Dredge & Dock CORP (GLDD) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $256.5M, roughly 1.2× Great Lakes Dredge & Dock CORP). Bio-Techne runs the higher net margin — 12.8% vs 4.9%, a 7.9% gap on every dollar of revenue. On growth, Great Lakes Dredge & Dock CORP posted the faster year-over-year revenue change (26.5% vs -6.4%). Over the past eight quarters, Great Lakes Dredge & Dock CORP's revenue compounded faster (13.6% CAGR vs 4.2%).
Great Lakes Dredge and Dock Company is an American company providing construction services in dredging and land reclamation, currently the largest such provider in the United States. GLD&D operates primarily in the United States but conducts one-quarter of its business overseas. The company was based in Oak Brook, Illinois, but in October 2020 relocated its corporate headquarters to Houston, Texas.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
GLDD vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $256.5M | $295.9M |
| Net Profit | $12.6M | $38.0M |
| Gross Margin | 20.9% | 64.6% |
| Operating Margin | 12.7% | 18.4% |
| Net Margin | 4.9% | 12.8% |
| Revenue YoY | 26.5% | -6.4% |
| Net Profit YoY | -35.9% | 68.3% |
| EPS (diluted) | $0.19 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $256.5M | $295.9M | ||
| Q3 25 | $195.2M | — | ||
| Q2 25 | $193.8M | $317.0M | ||
| Q1 25 | $242.9M | $316.2M | ||
| Q4 24 | $202.8M | $297.0M | ||
| Q3 24 | $191.2M | $289.5M | ||
| Q2 24 | $170.1M | $306.1M | ||
| Q1 24 | $198.7M | $303.4M |
| Q4 25 | $12.6M | $38.0M | ||
| Q3 25 | $17.7M | — | ||
| Q2 25 | $9.7M | $-17.7M | ||
| Q1 25 | $33.4M | $22.6M | ||
| Q4 24 | $19.7M | $34.9M | ||
| Q3 24 | $8.9M | $33.6M | ||
| Q2 24 | $7.7M | $40.6M | ||
| Q1 24 | $21.0M | $49.1M |
| Q4 25 | 20.9% | 64.6% | ||
| Q3 25 | 22.4% | — | ||
| Q2 25 | 18.9% | 62.7% | ||
| Q1 25 | 28.6% | 67.9% | ||
| Q4 24 | 24.1% | 65.3% | ||
| Q3 24 | 19.0% | 63.2% | ||
| Q2 24 | 17.5% | 66.4% | ||
| Q1 24 | 22.9% | 67.4% |
| Q4 25 | 12.7% | 18.4% | ||
| Q3 25 | 14.4% | — | ||
| Q2 25 | 8.8% | -7.5% | ||
| Q1 25 | 20.6% | 12.2% | ||
| Q4 24 | 14.8% | 16.0% | ||
| Q3 24 | 8.7% | 13.8% | ||
| Q2 24 | 8.6% | 15.0% | ||
| Q1 24 | 15.8% | 22.1% |
| Q4 25 | 4.9% | 12.8% | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 5.0% | -5.6% | ||
| Q1 25 | 13.8% | 7.1% | ||
| Q4 24 | 9.7% | 11.7% | ||
| Q3 24 | 4.6% | 11.6% | ||
| Q2 24 | 4.5% | 13.3% | ||
| Q1 24 | 10.6% | 16.2% |
| Q4 25 | $0.19 | $0.24 | ||
| Q3 25 | $0.26 | — | ||
| Q2 25 | $0.14 | $-0.11 | ||
| Q1 25 | $0.49 | $0.14 | ||
| Q4 24 | $0.29 | $0.22 | ||
| Q3 24 | $0.13 | $0.21 | ||
| Q2 24 | $0.11 | $0.26 | ||
| Q1 24 | $0.31 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.4M | $172.9M |
| Total DebtLower is stronger | $378.2M | $260.0M |
| Stockholders' EquityBook value | $517.1M | $2.0B |
| Total Assets | $1.3B | $2.5B |
| Debt / EquityLower = less leverage | 0.73× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.4M | $172.9M | ||
| Q3 25 | $12.7M | — | ||
| Q2 25 | $2.9M | $162.2M | ||
| Q1 25 | $11.3M | $140.7M | ||
| Q4 24 | $10.2M | $177.5M | ||
| Q3 24 | $12.0M | $187.5M | ||
| Q2 24 | $23.1M | $152.9M | ||
| Q1 24 | $22.8M | $145.3M |
| Q4 25 | $378.2M | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $448.2M | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $517.1M | $2.0B | ||
| Q3 25 | $502.1M | — | ||
| Q2 25 | $481.9M | $1.9B | ||
| Q1 25 | $479.9M | $2.0B | ||
| Q4 24 | $448.9M | $2.1B | ||
| Q3 24 | $425.4M | $2.1B | ||
| Q2 24 | $418.0M | $2.1B | ||
| Q1 24 | $409.0M | $2.0B |
| Q4 25 | $1.3B | $2.5B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.2B | $2.6B | ||
| Q1 25 | $1.2B | $2.6B | ||
| Q4 24 | $1.3B | $2.7B | ||
| Q3 24 | $1.1B | $2.7B | ||
| Q2 24 | $1.1B | $2.7B | ||
| Q1 24 | $1.1B | $2.7B |
| Q4 25 | 0.73× | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 1.00× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $79.7M | — |
| Free Cash FlowOCF − Capex | $50.3M | — |
| FCF MarginFCF / Revenue | 19.6% | — |
| Capex IntensityCapex / Revenue | 11.5% | — |
| Cash ConversionOCF / Net Profit | 6.31× | — |
| TTM Free Cash FlowTrailing 4 quarters | $99.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $79.7M | — | ||
| Q3 25 | $49.2M | — | ||
| Q2 25 | $56.9M | $98.2M | ||
| Q1 25 | $60.9M | $41.1M | ||
| Q4 24 | $-13.5M | $84.3M | ||
| Q3 24 | $26.8M | $63.9M | ||
| Q2 24 | $18.4M | $75.5M | ||
| Q1 24 | $38.4M | $81.0M |
| Q4 25 | $50.3M | — | ||
| Q3 25 | $13.2M | — | ||
| Q2 25 | $-3.7M | $93.3M | ||
| Q1 25 | $39.6M | $31.0M | ||
| Q4 24 | $-36.1M | $77.5M | ||
| Q3 24 | $-11.5M | $54.7M | ||
| Q2 24 | $-34.0M | $57.5M | ||
| Q1 24 | $26.5M | $64.5M |
| Q4 25 | 19.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | -1.9% | 29.4% | ||
| Q1 25 | 16.3% | 9.8% | ||
| Q4 24 | -17.8% | 26.1% | ||
| Q3 24 | -6.0% | 18.9% | ||
| Q2 24 | -20.0% | 18.8% | ||
| Q1 24 | 13.4% | 21.3% |
| Q4 25 | 11.5% | — | ||
| Q3 25 | 18.4% | — | ||
| Q2 25 | 31.3% | 1.5% | ||
| Q1 25 | 8.7% | 3.2% | ||
| Q4 24 | 11.2% | 2.3% | ||
| Q3 24 | 20.0% | 3.2% | ||
| Q2 24 | 30.8% | 5.9% | ||
| Q1 24 | 6.0% | 5.4% |
| Q4 25 | 6.31× | — | ||
| Q3 25 | 2.77× | — | ||
| Q2 25 | 5.87× | — | ||
| Q1 25 | 1.82× | 1.82× | ||
| Q4 24 | -0.69× | 2.42× | ||
| Q3 24 | 3.02× | 1.90× | ||
| Q2 24 | 2.39× | 1.86× | ||
| Q1 24 | 1.83× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GLDD
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
